| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 125.66M | 218.74% |
| Operating expense | — | — |
| Net income | -97.86M | -87.74% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2171.HK returned -37.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -10.1% |
| 1 year | -37.3% |
| 5 years | -66.8% |
| All-time high | $54.50 (Sep 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2171.HK would be worth today ›No. CARsgen Therapeutics Holdings Limited has not paid a dividend in the past 12 months.
CARsgen Therapeutics Holdings Limited is part of the Healthcare sector.
CARsgen Therapeutics Holdings Limited has a market cap of 7.53B HKD, based on the latest quote.
